Charles Elliott Sigal Transaction History

Date Transaction Value Shares Traded Form
Sep 08 2023
SELL
Sale (or disposition) back to the issuer
-
45,453

Also insider at

VIR
Vir Biotechnology, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
CES

Charles Elliott Sigal

Director
Cambridge, MA

Track Institutional and Insider Activities on SURF

Follow Surface Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SURF shares.

Notify only if

Insider Trading

Get notified when an Surface Oncology, Inc. insider buys or sells SURF shares.

Notify only if

News

Receive news related to Surface Oncology, Inc.

Track Activities on SURF